Skip to main content

Table 1 General overview: Patients with malignant primary disease in two hospices

From: Use of symptom-focused oncological cancer therapies in hospices: a retrospective analysis

Category and related p-valuea Hospice 1 (H1) Hospice 2 (H2) Total
Total number of patients 336 100% 370 100% 706 100%
Patients with malignant disease 312 93% 333 90% 645 91%
Evaluation: Patients with a malignant disease
Age in years (median, p = 0.98) 72 (range: 33–96) 72 (range: 42–101) 72 (range: 33–101)
Residence time in days (p = 0.66) 30 (range: 0–440) 26 (range: 0–335) 28 (range: 0–440)
Gender (p = 0.18)
 Male 141 45% 132 40% 273 42%
 Female 171 55% 201 60% 372 58%
Malignant disease (primary diagnosis)
 Bronchial carcinomas (p = 0.92) 56 18% 61 18% 117 18%
 Gastrointestinal cancers (p = 0.67) 97 31% 98 29% 195 30%
 Gynecological cancers (p = 0.03) 47 15% 73 22% 120 19%
 Brain cancers (p = 0.49) 25 8% 32 10% 57 9%
 ENT tract cancers (p = 0.57) 12 4% 16 5% 28 4%
 Other cancer (bone cancers, thyroid carcinomas, skin malignomas, cancer of unknown pirmary; p = 0.72) 14 5% 18 5% 32 5%
 Urological cancers (p = 0.78) 30 10% 29 9% 59 9%
 Haematological systemic diseases (p < 0.01) 31 10% 6 2% 37 6%
Clinical course
 Discharge (p = 1.00) 13 4% 13 4% 26 4%
 Hospitalization (p = 0.69) 2 1% 4 1% 6 1%
 For survival time see Fig. 1       
  1. a Refers to the comparison of the two hospices